Treatment of high stress Mental and Behavioural Disorders
Conditions
Sponsors
Universitat Autònoma de Barcelona
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Between the ages of 18 – 75 years 2. Comply with eligibility criteria to access and take part on the evaluated intervention 3. Stress interference in daily life being significantly or very significantly (as assessed by the screening questionnaire) 4. Either: often or very often experiences of discrimination or prejudices in daily life OR Yes-experiencing persistent poor sleep quality/poor mood/low energy levels/sadness/fatigue/anxiety (as assessed by the screening questionnaire) 5. No previous (last month) or current participation in the same type of nature-based therapy we are evaluating
Exclusion criteria
Exclusion criteria: 1. Intellectual disability (ICD-11 6A00) 2. Phobias that can highly impact the capacity to benefit from our evaluated interventions, such as social and insect-related phobias (ICD-11 6B02, 6B03, 6B04) 3. Dissociative behaviours (ICD-11 6B60, 6B61, 6B62, 6B63, 6B64, 6B65, 6B66, 6E65, 6B6Y, 6B6Z) 4. Mental or behavioural symptoms, signs or clinical findings that can highly impact the capacity of the intervention group to benefit from our evaluated interventions or that increases their potential to become difficult cases to handle by guides (ICD-11 MB23.0, MB23.R, MB23.S)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At Screening/Baseline, 10 weeks (end of intervention), 14 weeks, and 22 weeks for the intervention group and at Screening/Baseline, 10 weeks, 20 weeks (end of intervention, for those who choose to enrol in the intervention after the initial waitlist period), and 24 weeks for the waitlist group: 1. Perceived stress (measured using the Perceived Stress Scale 10 items, PSS-10) 2. Quality of life (EuroQol 5 Dimensions 5 levels, EQ-5D-5L) 3. Wellbeing (ONS-4) | — |
Secondary
| Measure | Time frame |
|---|---|
| At Screening/Baseline, 10 weeks (end of intervention), 14 weeks, and 22 weeks for the intervention group and at Screening/Baseline, 10 weeks, 20 weeks (end of intervention, for those who choose to enrol in the intervention after the initial waitlist period), and 24 weeks for the waitlist group: 1. Anxiety (Generalized Anxiety Disorder-7 (GAD-7) 2. Sleep quality (PSQI-2) 3. Emotional regulation (Difficulties in Emotion Regulation Scale, DERS-16) 4. Self-esteem (Rosenberg Self-esteem Questionnaire, RSES) | — |
Countries
Spain
Contacts
Public ContactMargarita Triguero-Mas
Outcome results
None listed